uBiome

Company

Investment-firm

Last deal

$83M

Amount

Series C

Stage

21.09.2018

Date

8

all rounds

$109.9M

Total amount

General

About Company
uBiome is a provider of DNA sequencing technology for the microbiome.

Industry

Sector :

Subsector :

Keywords :

founded date

01.11.2012

Number of employees

Company Type

For Profit

Last funding type

Series C

IPO status

Private

Description

uBiome is a citizen science startup that offers public access to cutting-edge sequencing technology and a data platform to gather, analyze, and translate data about the human microbiome. The company has developed the first sequencing-based clinical microbiome tests and combines precision sequencing with machine learning and artificial intelligence to advance the science of the microbiome. uBiome is committed to empowering patients and healthcare providers to understand and take greater control of their health by providing actionable insights and information about the microbiome. With their clever genetic analysis technology, uBiome offers in-depth microbiome tests that provide one-of-a-kind results with actionable takeaways that can bring about measurable change to one's health.
Contacts

Phone number

Social url